Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. FDA-2015-N-0001]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice of public conference. The Food and Drug Administration (FDA) Cincinnati District, in cosponsorship with Xavier University, is announcing a public conference entitled “FDA/Xavier University Global Medical Device Conference (MedCon).” This 3-day public conference includes presentations from key FDA officials and industry experts with small group breakout sessions. The conference is intended for companies of all sizes and employees at all levels.
 DATES: *Dates and Times:*
                         The public conference will be held on May 6, 2015, from 8:30 a.m. to 5 p.m.; May 7, 2015, from 8:30 a.m. to 5 p.m.; and May 8, 2015, from 8:30 a.m. to 12:30 p.m. *Location:*
                         The public conference will be held on the campus of Xavier University, 3800 Victory Pkwy., Cincinnati, OH 45207, 513-745-3016. *Contact Persons: For information regarding this notice:*
                         Gina Brackett, Food and Drug Administration, 6751 Steger Dr., Cincinnati, OH 45237, 513-679-2700, FAX: 513-679-2771, email: 
                        *gina.brackett@fda.hhs.gov.* *For information regarding the conference and registration:*
                         Mason Rick, Xavier University, 3800 Victory Pkwy., Cincinnati, OH 45207-5471, 513-745-3016, email: 
                        *rickm@xavier.edu,*
                         or visit 
                        *http://www.XavierMedCon.com.* *Registration:*
                         There is a conference registration fee which covers the cost of the presentations, training materials, receptions, breakfasts, and lunches for the 3 days of the conference. Advanced registration begins February 6, 2015. Standard registration begins March 6, 2015. There will be onsite registration. The cost of registration is as follows:
                        ( print page 8328) Table 1—Registration Fees 1
Attendee type
Advanced rate 
                             (2/6/15 to 3/5/15)
Standard rate 
                             (after 3/5/15)Industry
$1,495
$1,695Small Business (<100 Employees)
1,000
1,200Startup Manufacturer
250
300Academic
250
300FDA/Government Employee
Free
Free1
                         The following forms of payment will be accepted: American Express, Visa, MasterCard, and company checks.
 To register online for the public conference, please visit the “Registration” link on the conference Web site at 
                    *http://www.XavierMedCon.com.*
                     FDA has verified the Web site address, but is not responsible for subsequent changes to the Web site after this document publishes in the 
                    **Federal Register**
                    . To register by mail, please send your name, title, firm name, address, telephone, email, and payment information for the fee to Xavier University, Attention: Mason Rick, 3800 Victory Pkwy., Cincinnati, OH 45207-5471. An email will be sent confirming your registration. Attendees are responsible for their own accommodations. The conference headquarters hotel is the Downtown Hilton Cincinnati Netherland Plaza, 35 West Fifth St., Cincinnati, OH 45202, 513-421-9100. Special conference block rates are available through April 16, 2015. To make reservations online, please visit the “Venue/Logistics” link at 
                    *http://www.XavierMedCon.com.* If you need special accommodations due to a disability, please contact Mason Rick (see 
                    *Contact Persons*) at least 7 days in advance of the conference.


SUPPLEMENTARY INFORMATION: The public conference helps fulfill the Department of Health and Human Services' and FDA's important mission to protect the public health. The conference will provide those engaged in FDA-regulated medical devices (for humans) with information on the following topics: Center Director Corner: Strategic Priorities for 2015 and Beyond
                Office of Compliance Strategic Priorities
                Advancements in Medical Device Software Technology
                Understanding and Preparing for the Revision of ISO13485
                Update from FDA's Office of Combination Products
                Unique Device Identification—Implementation
                FDA Inspections and Insights
                Understanding the Current Activities of the International Medical Device Regulators Forum
                European Union Medical Device/In Vitro Diagnostics Regulation Review
                Update from the Office of Device Evaluation
                Regulatory Submissions and Strategies
                Complaints, Corrective and Preventive Actions, and Recalls
                Regulatory Challenges in Asia
                Action Plan Writing
                Lunch Networking by Topic FDA has made education of the drug and device manufacturing community a high priority to help ensure the quality of FDA-regulated drugs and devices. The conference helps to achieve objectives set forth in section 406 of the Food and Drug Administration Modernization Act of 1997 (21 U.S.C. 393), which includes working closely with stakeholders and maximizing the availability and clarity of information to stakeholders and the public. The conference also is consistent with the Small Business Regulatory Enforcement Fairness Act of 1996 (Public Law 104-121) by providing outreach activities by Government agencies to small businesses. Dated: February 10, 2015. Leslie Kux, Associate Commissioner for Policy.


[FR Doc. 2015-03116 Filed 2-13-15; 8:45 am] BILLING CODE 4164-01-P